《大行報告》瑞信上調百勝中國(09987.HK)目標價至559元 評級「跑贏大市」
瑞信發表報告指,百勝中國(09987.HK)(YUMC.US)今年首季收入按年增長46%至25.57億美元,經調整純利更按年上升271%至2.33億美元,分別優於市場預期15%及24%。增長強勁主要是由肯德基門店擴張、必勝客同店銷售復甦,及此兩品牌的毛利率改善至2019年同季相若水平所推動。
該行上調百勝中國股份目標價,由512元升至559元,評級維持「跑贏大市」,並調升集團今年盈利預測7%。瑞信預期,集團今年可錄10%的單位增長,同店銷售則料升9%,至於餐廳毛利率估計為16.5%。(ek)~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.